Petach Tikva, Israel

Ofer Sharon

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Location History:

  • Petach Tikva, IL (2012 - 2013)
  • Petach Tikvah, IL (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ofer Sharon: Innovator in Isoquinolinium Compounds

Introduction

Ofer Sharon is a notable inventor based in Petach Tikva, Israel. He has made significant contributions to the field of medicinal chemistry, particularly in the development of isoquinolinium compounds. With a total of 3 patents to his name, Sharon's work has the potential to impact the pharmaceutical industry.

Latest Patents

One of Ofer Sharon's latest patents is focused on isoquinolinium compounds that are useful in the preparation of cisatracurium and its associated intermediates. This invention provides novel isoquinolinium compounds, methods for producing these compounds, and techniques for converting them into cisatracurium, specifically cisatracurium besylate. The isoquinolinium compounds can be obtained in solid form, which can be purified using simple techniques, allowing for the production of pure cisatracurium besylate without the need for HPLC purification. Another patent involves R,R'-atracurium salts, detailing processes for producing and purifying these salts, as well as methods for using them to create highly pure cisatracurium besylate.

Career Highlights

Ofer Sharon is associated with Chemagis Ltd., where he continues to innovate and develop new compounds. His work is characterized by a commitment to advancing medicinal chemistry and improving pharmaceutical formulations.

Collaborations

Sharon collaborates with talented individuals in his field, including Oded Arad and Vladimir Naddaka. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Ofer Sharon is a prominent inventor whose work on isoquinolinium compounds has the potential to significantly influence the pharmaceutical industry. His innovative approaches and collaborations highlight his dedication to advancing medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…